Studies of hepatocyte proliferation during physiologic growth of the rat and after experimental stimulations such as partial hepatectomy and injection of irritants show that an inhibitory mechanism is associated with decreasing proliferation and causes hepatocytes to be less sensitive to mitotic stimuli. An inhibitory glycopeptide linked to a high molecular weight protein, a,-macroglobulin in man, has been characterized. This glycopeptide blocks the cell cycle of hepatocytes at the G,-S transition in v i m
INTRODUCTION
Hepatocyte proliferation control has been the subject of.many works or publications but is still not well understood. It is probably the result of the positive or negative influence of multiple factors which integrate the needs of the organism, i.e., the functional load, and the balance between liver and body weight. No global explanation of this control is currently available. In this paper we will describe some aspects ofrat hepatocyte proliferation and the data we obtained in favor of an inhibitory mechanism as part of this control.
BODY GROWTH AND LIVER GROWTH Rat body growth is exponential during the first weeks of life with a mean doubling time of 6 to 7 days during the first 2 weeks and of 12 to 14 days, from day 15 to day 30. Later, males grow faster than females. In our strain of Wistar rats, liver weight is 3.5% of body weight until day 20 and increases to 5% at day 30 ( Fig. 1) .
These livers exhibit two successive growth periods with sharp differences in hepatocyte proliferation ( Fig. 2A ). Just after birth, hepatocyte proliferation is low, but increases rapidly to reach a plateau before the fourth day. From the fourth to the 20th day, liver growth is due to hepatocyte proliferation. The mean labelling index (LI) is around 4.5% and, since S phase duration is 8 hours (9, 12, 19) , that means an increase of 13.5% per day and a doubling time of Bdays, in good accordance with body growth.
After the 20th day a second period of growth be-gins. Hepatocyte proliferation decreases rapidly to reach very low adult values after the 30th day:Liver growth is due partly to hepatocyte proliferation and partly to hypertrophy of the cell cytoplasm. In addition, 2 phenomena appear: (a) a nyctemeral rhythm with a LI higher at night (2), and (b) polyploidization of hepatic cells in several stages. First, binucleated cells are formed by mitosis without cytokinesis. Then each binucleated cell becomes the origin of a clone ofpolyploid cells after mitosis with only one spindle (10, 11).
STIMULATION OF HEPATOCYTE PROLIERATION
Hepatocyte proliferation may be stimulated in adult or in young rats in several ways. Partial hepatectomy is the best known method to induce hepatocyte proliferation in adult or juvenile rats. DNA synthesis begins 18 to 20 hours after surgery and cell proliferation lasts 5 to 7 days until liver mass is restored (4). Partial destruction of liver parenchyma by toxins such as carbon tetrachloride also induces a regenerative proliferation.
Administration of various chemicals, which do not cause liver injury but are metabolized and detoxified by the liver, results in additive growth and enlargement of the liver. In adult rats, enlargement is due to cell hypertrophy but in young rats it is due to both proliferation and hypertrophy (20) .
Nutritional stimuli have been shown to interfere with hepatocyte proliferation. Proliferation is increased by high protein diets in growing rats (1, 24) and it has been shown that protein consumption has a permissive role for the progression of hepatocytes and T3 into adult rats induces a rise of DNA synthesis to the same extent as after partial hepatectomy (23) .
EFFECT OF ACUTE INFLAhlhlATION ON HEPATOCYTE PROLIFERATION IN BAnY RATS
In our laboratory we have studied the stimulation of hepatocyte proliferation after injection of imtating substances (1 2). A subcutaneous injection of alkaline casein solution or ofturpentine induces the liver to synthesize acute-phase proteins by a mechanism, not yet fully understood, that probably involves specific factors from macrophages and hormones, particularly glucocorticoids. A stronger stimulation of hepatocyte proliferation is also recorded in young rats.
In 10-day-old rats of 20 g of body weight, a subcutaneous injection of casein solution induces 15 to 20% of hepatocytes to initiate synchronized cycles. Synchronized cells enter the S phase between 14 and 17 hours, stay in S phase from 17 to 23 hours (the LI is then five times above controls) and leave S phase after 23 hours. The peak ofmitosis is between 24 and 27 hours. After 30 hours there is a decrease of hepatocyte proliferation until day 5 (Fig. 3A) .
We used this synchronization of hepatocytes to test for proliferation-inhibiting factors. Products under study may be injected at various times in the cell cycle. The active products that we found blocked the cells at the end of the G, phase 8 to 13 hours, so fewer cells were recorded in S phase at 17 to 23 hours or in mitosis at 24 to 27 hours. Inhibition is the percent reduction of the LI at 20 hours compared to saline-injected controls of the same litter (13) .
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After day 20, hepatocyte proliferation decreases sharply and reaches very low values after day 30 ( Fig. 2A) . Concomitantly, Fig. 2B shows that the proliferation induced by injection ofirritants is very weak after day 20, but slightly higher in females (8, 12). We found an inhibitory activity in blood serum and liver cytosol of adult rats. This inhibitory activity was not found in baby rats and was first recorded at 24 days (18) . After partial hepatectomy in adults, inhibitory activity was suppressed in serum during the regenerative period but was still found in liver cytosol(l4).
In baby rats, during the course of hepatocyte synchronization by irritants, a second injection produces variable effects according to the interval of time between the two injections ( Fig. 3B ). During the first 4 hours there is an almost totally unresponsive period, which may correspond to exhaustion of mediators of the process. At 8, 12 and 18 hours, the second injection induces synchronized cell cycles which result in a 10% increase of the LI 20 hours later, which is more than half the effect of the first injection. At 42 and 84 hours, during the period of low proliferation, a second injection results in a very low increase ofthe LI. At day 5 , when proliferation is back to normal values, a second injection induces a 5% increase of the LI, which is large but still only one third the effect of the first injection. Inhibitory activity was found in serum and liver cytosol of baby rats at 30 and 48 hours after synchronization (Fig. 3C) .
Although other explanations could be given, a likely hypothesis is that an inhibitory system is at least partly responsible for the decrease of hepatocyte multiplication. This inhibitory system would prevent hepatocytes from reacting to stimuli such as irritants. Schulte-Hermann reached similar conclusions about hepatocyte response to xenobiotic inducers of mono-oxygenase activity (2 1). Conversely, if this hypothesis is true, the response to an irritating injection could be a test to determine if a hepatocyte or hepatocyte-derived population is inhibited or not.
CHARACTERIZATION OF INHIBITORY FACTORS
Purification of the inhibitory factor in blood showed that its activity was linked to high molecular weight globulins (1 6). Treatment ofcrude or purified serum proteins with proteolytic enzymes (trypsin, chymotrypsin) or adult rat liver microsomal frac-tions resulted in the production of a low molecular weight factor separated by ultrafiltration through a Diaflo PM 10 membrane and concentrated on UM 0.5 (17) . Sephadex gel filtration and enzymatic treatment showed that it was a glycopeptide of about 1,400 molecular weight and is sensitive to pronase, papain, and the association of neuraminidase and 19-galactosidase (7). It blocks the cell cycle of hepatocytes at the end of the G , phase and has been found active not only upon the proliferation of synchronized baby rat hepatocytes but also on the proliferation of hepatocytes in normal baby rats and after partiaI hepatectomy in young adults (Nadal, unpublished data) .
Study of the high molecular weight protein which generates the glycopeptide has shown that activity exists in human blood and that it closely cofractionates with and probably is a,-macroglobulin, one of the major antiproteases (3).
Our inhibitory glycopeptide may be compared to some inhibitory factors studied in other laboratories (15) . It might be analogous to the low molecular weight inhibitory factor that Sekas and Cook detected by its activity on hepatocyte proliferation after partial hepatectomy (22) . It is probably different from the 26,000 molecular weight protein active in vitro on near normal hepatocyte cell lines studied by Iype and McMahon (6).
In conclusion, inhibitory mechanisms cannot completely explain the control of hepatocyte proliferation. In particular they are not a permanent fact throughout life but appear in the second part of growth causing hepatocytes to be less sensitive to mitotic stimuli. This control probably also involves positive factors: hormones and growth factors without strict target specificity and possibly factors specific for hepatocytes.
The existence of an inhibitory system of hepatocyte proliferation raises an interesting problem, since its loss could lead to changes which give the premalignant or malignant cells a proliferative advantage over normal hepatocyte populations. 
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